Bone metabolism and peritoneal membrane transport in children on chronic peritoneal dialysis

Helena Ziólkowska1, Malgorzata Pańczyk-Tomaszewska, Andrzej Debiński

  • 1Department of Paediatrics & Nephrology, Medical University of Warsaw, University Children's Hospital, Warsaw, Poland. nefrologia@litewska.edu.pl

Insights

Peritoneal membrane permeability influences bone metabolism in children undergoing peritoneal dialysis (PD). High permeability correlated with lower bone formation rates, suggesting a link between dialysis efficiency and bone health.

Area of Science:

  • Nephrology
  • Pediatrics
  • Bone Metabolism

Background:

  • Peritoneal dialysis (PD) is a common treatment for end-stage renal failure in children.
  • Bone metabolism is often affected in children with chronic kidney disease.
  • The role of peritoneal membrane characteristics in bone health is not fully understood.

Purpose of the Study:

  • To investigate the relationship between peritoneal membrane permeability and bone metabolism in pediatric patients on PD.
  • To assess if high peritoneal transport influences bone turnover markers and bone histology.

Main Methods:

  • 24 children on PD were categorized into high (Group I) and other (Group II) peritoneal transport groups based on the peritoneal equilibration test.
  • Serum levels of calcium, phosphorus, albumin, and parathyroid hormone were measured.
  • Bone biopsies were analyzed for osteoclast surface and bone formation rate.

Main Results:

  • No significant differences in biochemical markers or demographics were observed between groups.
  • Children with high peritoneal transport (Group I) exhibited significantly lower osteoclast surface and bone formation rates compared to Group II.
  • A positive correlation was found between high dialysate-to-serum creatinine ratio (D/P) and bone formation rate.

Conclusions:

  • Peritoneal membrane permeability may play a role in modulating bone turnover in children undergoing PD.
  • Further research is needed to elucidate the mechanisms linking peritoneal transport and bone health in this population.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...